Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Metagenome-Assembled Genomes (MAGs) Services Global Market Report 2026 | Capitalize on 15.9% CAGR Through 2030 with AI and Long-Read Sequencing: Thermo Fisher, QIAGEN, BGI Genomics

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a key player in the Metagenome-Assembled Genomes (MAGs) Services market, which is experiencing significant growth driven by AI and long-read sequencing. The article does not provide specific sentiment towards Thermo Fisher but lists it among companies in this expanding sector. QGEN QIAGEN is listed as a key company in the Metagenome-Assembled Genomes (MAGs) Services market, which is projected for strong growth. The article does not offer specific details or sentiment about QIAGEN's performance or prospects within this market.

Metagenome-Assembled Genomes (MAGs) Services Global Market Report 2026 | Capitalize on 15.9% CAGR Through 2030 with AI and Long-Read Sequencing: Thermo Fisher, QIAGEN, BGI Genomics Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "Metagenome-Assembled Genomes (MAGs) Services Global Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global metagenome-assembled genomes (MAGs) services market is experiencing rapid expansion, supported by advances in sequencing technologies, bioinformatics, and microbiome research. The market is projected to grow from $1.38 billion in 2025 to $1.60 billion in 2026, representing a compound annual growth rate (CAGR) of 15.7%.

Historical market growth has been driven by improvements in next-generation sequencing technologies, wider availability of high-throughput sequencing platforms, increased funding for environmental microbiology, and the continued expansion of bioinformatics expertise and infrastructure. These developments have enabled research organizations and biotechnology companies to analyze complex microbial communities with greater accuracy and efficiency.

The metagenome-assembled genomes services market is forecast to reach $2.89 billion by 2030, expanding at a CAGR of 15.9% from 2026. Growth during the forecast period is expected to be supported by rising demand for precision microbiome-based therapeutics, increased adoption of artificial intelligence-driven genome reconstruction tools, and broader use of microbial analysis in agriculture. Additional growth factors include the expansion of cloud-based bioinformatics services and heightened interest in exploring uncultured microbial diversity.

Key metagenome-assembled genomes services market trends include the growing adoption of hybrid genome assembly methods and increased demand for high-quality metagenome binning. Long-read sequencing is also gaining momentum as researchers seek to analyze complex microbiomes and reconstruct more complete microbial genomes. At the same time, providers are expanding functional and comparative genomics annotation capabilities and integrating customized, end-to-end bioinformatics pipelines into their service portfolios.

The increasing prevalence of infectious diseases is expected to strengthen demand for MAGs sequencing and bioinformatics services. Urbanization and higher population density can increase opportunities for pathogen transmission, creating a greater need for advanced microbial surveillance and analysis. MAGs services allow researchers to reconstruct microbial genomes from clinical and environmental samples, supporting pathogen identification, outbreak monitoring, microbial diversity analysis, and investigation of antimicrobial resistance mechanisms.

In March 2024, the Centers for Disease Control and Prevention reported that tuberculosis cases in the United States increased from 8,320 in 2022 to 9,615 in 2023. This rise of 1,295 cases illustrates the continuing need for technologies that can improve infectious disease research, microbial monitoring, and public health response capabilities.

Innovation remains a central competitive factor in the metagenome-assembled genomes services industry. Service providers are investing in high-resolution long-read sequencing, optimized sample preparation, high-fidelity analysis, and robust bioinformatics workflows. These capabilities can improve the accuracy and completeness of microbial genome reconstruction while reducing ambiguity in complex genome assemblies.

In April 2024, Clinical Microbiomics A/S launched advanced long-read 16S, ITS, 18S isolate, and metagenomics sequencing services. The offering combines optimized sample preparation, long-read sequencing, and bioinformatics pipelines to support detailed microbial identification and functional analysis. It is designed to help researchers investigate environmental, clinical, and gut microbiomes at higher resolution while supporting high-throughput studies. Potential applications include microbiome research, clinical diagnostics, and biotechnology development.

Market consolidation is also strengthening technical capabilities and broadening service coverage. In March 2024, Clinical Microbiomics A/S acquired DNASense ApS for an undisclosed amount. The acquisition was intended to integrate long-read DNA and RNA sequencing capabilities and expand microbiome services across human health, animal health, and environmental applications.

North America was the largest region in the metagenome-assembled genomes services market in 2025, while Asia-Pacific is expected to record the fastest growth during the forecast period. The market covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. Countries analyzed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy, and Spain.

Markets Covered:

1) By Service Type: Genome Assembly; Genome Annotation; Data Analysis; Custom Bioinformatics; Other Service Types

2) By Technology: Next-Generation Sequencing (NGS); Third-Generation Sequencing (Long-Read Sequencing); Cloud-Based Bioinformatics Platforms; Artificial Intelligence (AI) And Machine Learning-Based Analytics

3) By Application: Environmental Microbiology; Clinical Diagnostics; Agricultural Research; Biotechnology; Other Applications

4) By End-User: Academic and Research Institutes; Pharmaceutical and Biotechnology Companies; Contract Research Organizations; Other End-Users

Subsegments:

1) By Genome Assembly: De Novo Assembly; Reference Guided Assembly; Hybrid Assembly; Metagenome Binning; Quality Assessment and Validation

2) By Genome Annotation: Structural Annotation; Functional Annotation; Gene Prediction; Pathway Analysis; Comparative Genomics Annotation

3) By Data Analysis: Microbial Diversity Analysis; Taxonomic Classification; Metabolic Pathway Analysis; Statistical Data Interpretation; Visualization and Reporting

4) By Custom Bioinformatics: Workflow Development; Algorithm Optimization; Pipeline Integration; Data Management Solutions; Consulting and Technical Support

5) By Other Service Types: Data Storage and Management; Training and Support Services; Regulatory Compliance Assistance; Sample Preparation Consultation; Project Management Services

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Key Attributes:

Companies Featured

The companies featured in this Metagenome-Assembled Genomes (MAGs) Services market report include:

For more information about this report visit https://www.researchandmarkets.com/r/iyi0e8

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.